Cancer Research

The Global Lung Cancer Coalition Presents...The 3rd Annual Lung Cancer Journalism Awards Competition.

LONDON, September 16 /PRNewswire/-- The Lung Cancer Journalism Awards' mission: to raise global awareness of the leading cause of cancer-related deaths worldwide. Winners receive: Global showcase recognising their prize-winning work GBP2,000 research ...

Article - Anna Ohlden - Sep 16 2008 - 11:31am

Data From Three Trials Support Evidence Of Zometa(R) Anticancer Benefit In Pre- And Post-Menopausal Women With Early-Stage Breas

FRIMLEY, England, September 16 /PRNewswire/--- Findings Provide New Evidence for Potential Role of Zometa(R) to Help Reduce the Risk of Breast Cancer Returning New data from three clinical trials show Zometa(R) (zoledronic acid) reduced the risk of local ...

Article - Anna Ohlden - Sep 16 2008 - 1:31pm

Granzymes Attack Through Doors In Cell Pores

Our body is almost constantly being threatened by pathogens and cancerous cells that appear out of the blue, but our bodies put up a fight: specialized cells in the immune system smuggle small molecules (granzymes) into cancer cells and those body cells t ...

Article - News Staff - Sep 16 2008 - 5:46pm

Women: Half Of Early Deaths From Chronic Diseases Could Have Been Eliminated Through Lifestyle Changes

Over half of deaths in women from chronic diseases such as cancer and heart disease could be avoided if they never smoke, keep their weight in check, take exercise and eat a healthy diet low in red meat and trans-fats, according to a study published in BMJ ...

Article - News Staff - Sep 16 2008 - 9:23pm

Merck Serono Completes Enrollment In The REFLEX Trial Of Rebif(R) In Patients At Risk Of Developing Multiple Sclerosis

GENEVA, Switzerland, September 17 /PRNewswire/-- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment has been completed in the REFLEX trial (REbif FLEXible dosing in early multiple sclerosis). This randomize ...

Article - Anna Ohlden - Sep 17 2008 - 1:31am

Garmin T3 Gadget Awards 2008 Are Coming...

SOUTHAMPTON, England, September 17 /PRNewswire/-- Global leader in personal satellite navigation (PND) Garmin is proud to be the headline sponsor of the 2008 Garmin T3 Gadget Awards. The awards, which celebrate the hottest gadgets and coolest technologies ...

Article - Anna Ohlden - Sep 17 2008 - 4:32am

Latest RAD001 Study Results Show Further Increase In Time Without Tumour Growth In Patients With Advanced Kidney Cancer

FRIMLEY, England, September 17 /PRNewswire/--- New data, updated since ASCO, show time without tumour growth now reaches nearly 5 months with RAD001 vs. 1.9 months with placebo(1)- One quarter of patients in trial remained progression-free beyond ten mont ...

Article - Anna Ohlden - Sep 17 2008 - 8:32am

MicroRNA Interference Gets Some New Respect In Embryonic Stem Cell Research

Scientists from IBM and the Genome Institute of Singapore (GIS) say their report in Nature shows that microRNAs, those small molecules that are an important regulatory component in the machinery of living cells, have roles that go well beyond what was pre ...

Article - News Staff - Sep 17 2008 - 1:39pm

Diabetes Research: Human Skin Cells Turned Into Insulin-Producing Cells

Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. The breakthrough may one day lead to new treatments or even a cure ...

Article - News Staff - Sep 17 2008 - 8:22pm

AMT Obtains License To Amgen's GDNF Gene To Develop Treatment For Parkinson's Disease With AMT's Proprietary Gene Therapy Platfo

AMSTERDAM, The Netherlands, September 18 /PRNewswire/-- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from Amgen to use their GDNF gene for the development of a ge ...

Article - Anna Ohlden - Sep 18 2008 - 1:31am